The sales for the September 2024 quarter moved up 42.31% to Rs. 3700.00 millions as compared to Rs. 2600.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2024 is Rs. -360.00 millions as compared to Net Loss of Rs. -1070.00 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to 600.00% as compared to -40.00% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3700.00 2600.00 42.31 7220.00 5110.00 41.29 11540.00 10720.00 7.65
Other Income 110.00 60.00 83.33 380.00 120.00 216.67 410.00 670.00 -38.81
PBIDT 600.00 -40.00 -1600.00 1670.00 -30.00 -5666.67 50.00 1370.00 -96.35
Interest 530.00 590.00 -10.17 1110.00 1170.00 -5.13 2370.00 2290.00 3.49
PBDT 70.00 -630.00 -111.11 560.00 -1340.00 -141.79 -2460.00 -3270.00 -24.77
Depreciation 430.00 440.00 -2.27 860.00 880.00 -2.27 1760.00 1860.00 -5.38
PBT -360.00 -1070.00 -66.36 -300.00 -2220.00 -86.49 -4220.00 -5130.00 -17.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -470.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -470.00 0.00
PAT -360.00 -1070.00 -66.36 -300.00 -2220.00 -86.49 -4220.00 -4660.00 -9.44
Equity 770.00 720.00 6.94 770.00 720.00 6.94 770.00 720.00 6.94
PBIDTM(%) 16.22 -1.54 -1154.03 23.13 -0.59 -4039.74 0.43 12.78 -96.61

Wockhardt Share Price

1172.35 -14.60 (-1.23%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.